Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of UK-447,841 on vaginal blood flow in pre-menopausal women with Female Sexual Arousal Disorder
2004-001378-19Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of UK-447,841 in Sexual Arousal Disorder (6 arms), sponsored by Pfizer. Primary endpoints: Reproducibility of vaginal photoplethysmography (Part A) and Effect of UK-447,841 on vaginal blood flow (Part B). Started Aug 2004; status: completed.
02
Drugs
UK-447,841
03
Conditions
Sexual Arousal Disorder
Beyond the preview
Go deeper on 2004-001378-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001378-19.